All News

Kevin W. Cleveland, PharmD, urges evidence-based approaches to immunizations in an era of uncertainty.

Following his presentation at the American Diabetes Association’s 85th Scientific Sessions, Jon Easter caught up with Drug Topics to discuss the pharmacists’ role in diabetes management.

As state-level PBM reform heats up amid dire situations for many retail pharmacies, Walgreens Chief Pharmacy Officer Rick Gates joins Drug Topics to discuss ongoing industry challenges.

Patients who used the Bigfoot Unity Diabetes Management System had glycemic control and reduced diabetes distress.

Cherokee Layson-Wolf, PharmD, BCACP, FAPhA, discusses the impact of shifting guidance on vaccination strategies.

This episode explores how pharmacists can navigate their careers with clarity and purpose by grounding themselves in their professional oath, organizational mission, and core values.

As concerns mount over potential shifts in vaccine recommendations, Deanna Tran, PharmD, BCACP, FAPhA, advocates for rigorous data assessment and patient-centered communication strategies.

In part 3 of our interview with Walgreens Chief Pharmacy Officer Rick Gates, he explores the future of pharmacy practices and how modern use of technologies like AI are becoming commonplace.

In a recap of his presentation at the American Diabetes Association’s 85th Scientific Sessions, Jon Easter, RPh, discussed the role of pharmacists in team-based diabetes care.

Taylor Watterson, PharmD, PhD, discusses how pharmacy technician burnout can impact pharmacy operations.

Rob Frankil, RPh, discusses how independent pharmacies in Pennsylvania are dealing with the impact of Rite Aid stores closing.

Pharmacist-led deprescribing can help reduce the number of medications a patient is taking in an effective way.

Interest in community pharmacy practice is declining as pharmacists seek roles with better work-life balance, greater autonomy, and more meaningful patient care opportunities.

Walgreens Chief Pharmacy Officer Rick Gates discusses ongoing movement at the state level regarding pharmacy benefit manager reform.

In an abstract presented at the American Diabetes Association 85th Scientific Sessions, researchers tested the effectiveness of an AI-driven program for improving glycemic control.

Jon Easter, RPh, discusses pharmacists’ ability to improve patient engagement in diabetes care following his presentation at the American Diabetes Association’s 85th Scientific Sessions.

Pharmacists play a role in educating patients as well as making them feel more comfortable when utilizing opioid use treatment.

Rick Gates, chief pharmacy officer at Walgreens and chairman of the National Association of Chain Drug Stores, discussed the current status of retail pharmacies and the way they are reimbursed.

Pharmacists play a key role in medication for abortion care by providing clinical guidance, patient counseling, and advocacy.

Jon Easter, RPh, joined Drug Topics to discuss pharmacists’ roles within health care teams following his presentation at the American Diabetes Association’s 85th Scientific Sessions.

Of those who do not support vaccines, 79% said a major reason for their opposition is that it should be the parents’ choice about whether to vaccinate their child, and 40% cite safety concerns.

Clinical pharmacists transform diabetes care by leveraging manufacturer-sponsored patient assistance programs to dramatically improve medication access.

An ambulatory care pharmacist program in Washington State dramatically improved diabetes management by reducing A1c levels, increasing medication adherence, and providing comprehensive patient education.

ACIP also discusses COVID-19 epidemiology as well as safety and efficacy for the COVID-19 vaccines.

With the emergence of increased GLP-1 use and alternative PBM models, Morgan Lee, PhD, MPH, CPH, and Scott Halperin, PharmD, joined Drug Topics to discuss current trends in drug benefit design.

Results from the CATALYST trial showed patients who received mifepristone had a mean HbA1c reduction of 1.47%,

CD388 is being investigated as a prevention method for seasonal influenza in unvaccinated patients aged 18 to 64 years.